Back to top

Barclays Reaffirms Their Sell Rating on Addus Homecare (ADUS)

Barclays analyst Andrew Mok CFA maintained a Sell rating on Addus Homecare today and set a price target of $96.00. Mok CFA covers the Healthcare se...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Addus HomeCare Corporation (ADUS)